Walgreens treft $230 miljoen schikking met San Francisco over opioïden (2024)

FAQs

Did Walgreens pay San Francisco $229 million over opioid crisis? ›

In May 2023, the San Francisco City Attorney announced a nearly $230 million settlement agreement with Walgreens. This is the first bench trial to decide in the plaintiff's favor in the national opioid litigation, as well as the first bench trial to hold Walgreens liable.

Walgreens has agreed to pay $230 million to San Francisco for its role in the city's opioid epidemic following last year's landmark trial that found the pharmacy chain liable for not performing proper screenings. San Francisco City Attorney David Chiu announced the deal outside San Francisco City Hall today.

For anyone not aware, here's the background. In October 2021 Walgreens announced it was closing 5 stores in San Francisco due to losses from organized theft rings, after closing a number of stores earlier in the year for the same reason.

For years, Walgreens failed to perform due diligence or even train its pharmacists on how to recognize red flags for opioid abuse and diversion. Walgreens' pharmacies in Tennessee dispensed opioids to patients from at least 31 different states.

The settlement, a result of alleged Fair Credit Reporting Act violations, offers up to $918.28 to affected individuals.

State and local governments are receiving billions of dollars in settlements from companies that made, sold, or distributed prescription painkillers and were accused of fueling the opioid crisis. More than a dozen companies will pay the money over nearly two decades.

The settlement is a little over half of what Walgreens was originally ordered to pay, after an arbiter said the retail pharmacy chain overcharged Humana for prescription drugs for more than a decade. This audio is auto-generated.

Case Details

The Walgreens class action lawsuit further alleges that on June 27, 2024, Walgreens announced third quarter 2024 results below expectations and lowered fiscal year 2024 projections.

Cities and counties with a population greater than 10,000, based on the U.S. Census Bureau's population estimates for July 1, 2019 (released May 2020), are eligible to receive funds from the National Opioid Settlements.

Key Points. Walgreens shares plunged after the company lowered its EPS guidance. The company has been experiencing severe drug reimbursem*nt pressures, hurting margins and profitability. The stock has been thrown in the bargain bin, but a potential turnaround will take time.

What happened with Walgreens in California? ›

Today, at Governor Newsom's directive, DGS gave formal notice that it is withdrawing a planned renewal of that agreement set to take effect on May 1, 2023, and instead will explore other options for furnishing the same services. Under this contract, Walgreens has received about $54 million from the State.

The hashtag #boycottwalgreens has exploded on Twitter, fueled by abortion rights supporters who are angry over the pharmacy giant's plans to refuse to dispense abortion pills in 21 states, including four states where abortion remains legal.

Walgreens' share price hit its lowest level this century as retail pharmacies have suffered in recent years from reduced prescription drug revenue and staffing shortages, as well as competition with Amazon's online pharmacy business.

Please be aware that if you have received a link to this article in an email, text or by any other means, it is likely a scam. Stefano Pessina (born 4 June 1941) is an Italian-Monegasque billionaire businessman; he is the executive chairman and largest single shareholder of Walgreens Boots Alliance.

Workers have already been staging walkouts in scattered cities to protest working conditions that they say put customer safety at risk. The actions so far this month closed a handful of pharmacies briefly, and slowed business at several others; Walgreens told CNN the impact has been “minimal.”

(Walgreens), the nation's largest drug store chain, agreed to pay $80 million in civil penalties for violations of the Controlled Substances Act resolving administrative actions by the Drug Enforcement Administration (DEA), and Department of Justice civil investigations in the Eastern District of New York, the Southern ...

On the first federal workday of the new year, California Attorney General Rob Bonta announced a $5 billion settlement against drug store giant CVS over complicity in fueling the opioid crisis. California joined 18 states in the suit, garnering about $470 million out of the total $5 billion.

It started in the mid-1990s when the powerful agent OxyContin, promoted by Purdue Pharma and approved by the Food and Drug Administration (FDA), triggered the first wave of deaths linked to use of legal prescription opioids.

The United States alleged that these combination prescriptions, which OptumRx filled primarily from a mail order pharmacy location in Carlsbad, California, raised “red flags” indicating that the prescriptions may not have been intended for legitimate medical use and could lead to abuse or diversion of highly addictive ...